REQUEST A DEMO
Total
USD $0.00
FAQ
Secure shopping

Pharma & Healthcare

The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.

The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.

2 3 4 5 6
Romania Pharma and Healthcare Sector Report 2018/2019 - Page 1
Romania Pharma and Healthcare Sector Report 2018/2019 EMIS Insights Industry Reports

Expenditure on healthcare in Romania reached RON 35.2bn in 2015, according to data provided by Eurostat. Total expenditure on healthcare was equal to 4.94% of GDP in that year. The Romanian healthcare sector was characterised by the lowest per capita ...

View more details
USD 495 Date: July 2018 Language: English
Format: PDF
Add to basket
Hungary Pharma and Healthcare Sector Report 2018/2019 - Page 1
Hungary Pharma and Healthcare Sector Report 2018/2019 EMIS Insights Industry Reports

Total expenditure on healthcare in Hungary in 2015 reached HUF 2,460bn, up by 6.3% y/y. Government and compulsory health care financing schemes made up 67% of the expenditure, followed by private out-of-pocket spending (29%). Voluntary healthcare ...

View more details
USD 495 Date: June 2018 Language: English
Format: PDF
Add to basket
Poland Healthcare Sector Report 2017/2021 - Page 1
Poland Healthcare Sector Report 2017/2021 EMIS Insights Industry Reports

In 2016 Poland’s healthcare expenditure grew by 4.5% y/y to PLN 119.27bn, representing 6.4% of the GDP. Public healthcare spending in Poland is one of the lowest compared to the EU average, which hovers around 6.5 % of GDP. The bulk of the ...

View more details
USD 995 Date: April 2018 Language: English
Format: PDF
Add to basket
Russia Pharma and Healthcare Report 2018/2019 - Page 1
Russia Pharma and Healthcare Report 2018/2019 EMIS Insights Industry Reports

Russia’s healthcare and pharmaceutical sector was badly affected by the 2015-2016 recession, which resulted in a sharp drop in government spending, while the weak rouble and high inflation cut into households’ disposable incomes. Though ...

View more details
USD 495 Date: February 2018 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2017 4th Quarter - Page 1
China Healthcare Sector Report 2017 4th Quarter EMIS Insights Industry Reports

In Q3 2017 China continued to implement healthcare reforms which resulted in further development and growth of the sector. According to a health management summit held in Beijing in late 2017, the country’s healthcare market will reach RMB 4 ...

View more details
USD 495 Date: February 2018 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2017 3rd Quarter - Page 1
China Healthcare Sector Report 2017 3rd Quarter EMIS Insights Industry Reports

China's healthcare system is hospital-centric, with public hospitals delivering approximately 90% of the inpatient and outpatient care consumed in the country in both hospitals and basic medical institutions. Nearly 40% of hospitals’ revenue is ...

View more details
USD 495 Date: February 2018 Language: English
Format: PDF
Add to basket
Czech Republic Pharma and Healthcare Sector Report 2018/2019 - Page 1
Czech Republic Pharma and Healthcare Sector Report 2018/2019 EMIS Insights Industry Reports

The pharmaceutical sector in the Czech Republic generated a gross value added (GVA) of CZK 18.9bn in 2016, up by 8.2% y/y in real terms. It accounted for 0.44% of the total GVA in the economy in 2016. The sector employed 9,438 workers. Total ...

View more details
USD 495 Date: January 2018 Language: English
Format: PDF
Add to basket
Brazil Pharma & Healthcare Sector Report 2017/2021 - Page 1
Brazil Pharma & Healthcare Sector Report 2017/2021 EMIS Insights Industry Reports

Brazil is the eighth-largest pharmaceutical market in the world. In 2016, the retail drug market, based on ex-factory prices, rose by 15.5% y/y to BRL 87.2bn, supported by upward price dynamics and steady demand for innovative patented drugs. In ...

View more details
USD 995 Date: November 2017 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2017 2nd Quarter - Page 1
China Healthcare Sector Report 2017 2nd Quarter EMIS Insights Industry Reports

China's healthcare system is hospital-centric, with public hospitals delivering approximately 90% of the inpatient and outpatient care consumed in the country in both hospitals and basic medical institutions. Nearly 40% of hospitals’ revenue is ...

View more details
USD 495 Date: November 2017 Language: English
Format: PDF
Add to basket
India Healthcare and Pharmaceuticals Sector Report 2016/2017 - Page 1
India Healthcare and Pharmaceuticals Sector Report 2016/2017 EMIS Insights Industry Reports

India’s 1.3-bn population has given rise to a sizeable healthcare sector and one of the largest pharmaceutical markets in Asia. Both the healthcare and drug markets are plagued by uneven geographical spread, low levels of public expenditure and ...

View more details
USD 495 Date: August 2017 Language: English
Format: PDF
Add to basket
2 3 4 5 6